Van Eck Associates Corp Abbott Laboratories Transaction History

Van Eck Associates Corp

$88.3 Billion
Q2 2025

A detailed history of Van Eck Associates Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Van Eck Associates Corp holds 353,472 shares of ABT stock, worth $47.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

353,472

Previous 31,624 1017.73%

Holding current value

$47.6 Million

Previous $4.2 Million 1046.03%

% of portfolio

0.05%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$123.95 - $138.08 $39.9 Million - $44.4 Million	321,848 Added 1017.73%	353,472 $48.1 Million
Q1 2025 May 15, 2025	BUY	$111.1 - $140.22 $326,745 - $412,387	2,941 Added 10.25%	31,624 $4.2 Million
Q4 2024 Jan 29, 2025	BUY	$111.93 - $119.39 $107,117 - $114,256	957 Added 3.45%	28,683 $3.24 Million
Q3 2024 Oct 29, 2024	SELL	$100.07 - $118.13 $346,042 - $408,493	-3,458 Reduced 11.09%	27,726 $3.24 Million
Q2 2024 Jul 31, 2024	BUY	$100.73 - $112.44 $153,311 - $171,133	1,522 Added 5.13%	31,184 $3.24 Million
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $1.3 Million - $1.43 Million	-11,841 Reduced 28.53%	29,662 $3.37 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $20.7 Million - $25.4 Million	-229,700 Reduced 84.7%	41,503 $4.57 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $166,317 - $199,553	-1,741 Reduced 0.64%	271,203 $26.3 Million
Q2 2023 Aug 03, 2023	BUY	$100.78 - $112.29 $1.25 Million - $1.4 Million	12,426 Added 4.77%	272,944 $29.8 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $3.46 Million - $4.07 Million	35,707 Added 15.88%	260,518 $26.4 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $351,436 - $412,289	-3,697 Reduced 1.62%	224,811 $24.7 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $1.4 Million - $1.62 Million	14,456 Added 6.75%	228,508 $22.1 Million
Q2 2022 Aug 03, 2022	BUY	$102.07 - $123.37 $19 Million - $22.9 Million	185,814 Added 658.03%	214,052 $23.3 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $52,677 - $64,236	462 Added 1.66%	28,238 $3.34 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $59,151 - $72,427	512 Added 1.88%	27,776 $3.91 Million
Q3 2021 Nov 03, 2021	BUY	$116.66 - $129.06 $366,079 - $404,990	3,138 Added 13.01%	27,264 $3.22 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $9,415 - $11,083	-89 Reduced 0.37%	24,126 $2.8 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $653,801 - $770,277	6,007 Added 32.99%	24,215 $2.9 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $11,130 - $12,128	106 Added 0.59%	18,208 $1.99 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $2.29 Million - $2.78 Million	-25,012 Reduced 58.01%	18,102 $1.97 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $1.04 Million - $1.33 Million	-13,609 Reduced 23.99%	43,114 $3.94 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $841,662 - $1.23 Million	-13,398 Reduced 19.11%	56,723 $4.48 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $211,662 - $235,630	2,696 Added 4.0%	70,121 $6.09 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $174,646 - $189,371	2,134 Added 3.27%	67,425 $5.64 Million
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $426,712 - $497,675	5,855 Added 9.85%	65,291 $5.49 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $1.23 Million - $1.48 Million	-18,524 Reduced 23.76%	59,436 $4.75 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $464,885 - $526,648	7,091 Added 10.01%	77,960 $5.64 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $331,171 - $399,518	5,446 Added 8.32%	70,869 $5.2 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $3.77 Million - $4.16 Million	65,423 New	65,423 $3.99 Million

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Abbott Laboratories Transaction History